(Sr) Product Manager at Bristol-Myers Squibb

New Taipei City, New Taipei City, Taiwan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Demonstrate high standards of BMS behaviors: Integrity, Innovation, Urgency, Passion, Accountability, Inclusion
Minimal of 2 years marketing experiences in pharmaceutical industry (Oncology products preferable)
Fluent in Mandarin and English written/oral communication
Ability to connect with cross-functional colleagues and external stakeholders
Understanding the operational model of a multinational pharmaceutical company
Able to learn disease knowledge and product knowledge very quickly
Demonstrated ability to develop marketing plan independently and implement marketing initiatives timely through cross-functional work
Demonstrated ability to use creative and effective ways to execute marketing projects, especially in problem solving
Demonstrated ability to effectively communicate with individuals internally and externally
Demonstrated ability to work with various audiences at multiple levels and culturally diverse to deliver business expectations
Demonstrated good interpersonal skill and team work
Be knowledgeable on cancer disease, treatment, medical terms, and clinical trials

Responsibilities

Delivers results in line with product/business plan and company goals
Develop comprehensive product plan to interpret complicated marketplace, product status, and customer & patient insights; generates strategic imperatives and competitive tactics
Leads marketing programs timely across all functions, ensuring they meet strategic goals and align with product messages
Analyze complex marketplace issues through market research data and collect competitor intelligence to develop clear understanding of internal and external environment
Keep observing new competitors, treatments development, and industry updates
Establishes strong relationship with thought leaders and relevant societies to ensure endorsement of products and company

Skills

Product Management

Market Research

Competitor Intelligence

Oncology

Clinical Trials

Strategic Planning

Marketing Programs

Thought Leadership

Cross-Functional Leadership

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free